PH19998A - Hexahydropyrrolo 1,2-a quinoline,hexahydro-1h-pyrido 1,2-a quinoline,hexahydrobenzo e indene and octahydrophenanthrene cns agents - Google Patents

Hexahydropyrrolo 1,2-a quinoline,hexahydro-1h-pyrido 1,2-a quinoline,hexahydrobenzo e indene and octahydrophenanthrene cns agents

Info

Publication number
PH19998A
PH19998A PH28641A PH28641A PH19998A PH 19998 A PH19998 A PH 19998A PH 28641 A PH28641 A PH 28641A PH 28641 A PH28641 A PH 28641A PH 19998 A PH19998 A PH 19998A
Authority
PH
Philippines
Prior art keywords
quinoline
octahydrophenanthrene
hexahydrobenzo
hexahydropyrrolo
pyrido
Prior art date
Application number
PH28641A
Other languages
English (en)
Inventor
James Frederick Eggler
Michael Ross Johnson
Lawrence Sherman Melvin Jr
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PH19998A publication Critical patent/PH19998A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C35/00Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C35/22Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/14Antitussive agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/27Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups
    • C07C205/33Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups or etherified hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/18Monohydroxylic alcohols containing only six-membered aromatic rings as cyclic part
    • C07C33/20Monohydroxylic alcohols containing only six-membered aromatic rings as cyclic part monocyclic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/16Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/04Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78Ring systems having three or more relevant rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D455/00Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/03Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/04Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/02Ortho- or ortho- and peri-condensed systems
    • C07C2603/04Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/22Ortho- or ortho- and peri-condensed systems containing three rings containing only six-membered rings
    • C07C2603/26Phenanthrenes; Hydrogenated phenanthrenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Psychiatry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
PH28641A 1982-03-16 1983-03-14 Hexahydropyrrolo 1,2-a quinoline,hexahydro-1h-pyrido 1,2-a quinoline,hexahydrobenzo e indene and octahydrophenanthrene cns agents PH19998A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/358,569 US4476131A (en) 1982-03-16 1982-03-16 Substituted hexahydropyrrolo[1,2-a]-quinolines, hexahydro-1H-pyrido[1,2-a]-q

Publications (1)

Publication Number Publication Date
PH19998A true PH19998A (en) 1986-08-28

Family

ID=23410189

Family Applications (1)

Application Number Title Priority Date Filing Date
PH28641A PH19998A (en) 1982-03-16 1983-03-14 Hexahydropyrrolo 1,2-a quinoline,hexahydro-1h-pyrido 1,2-a quinoline,hexahydrobenzo e indene and octahydrophenanthrene cns agents

Country Status (27)

Country Link
US (1) US4476131A (ru)
EP (1) EP0090516B1 (ru)
JP (2) JPS58170724A (ru)
KR (2) KR870001126B1 (ru)
AR (1) AR240936A1 (ru)
AT (1) ATE35544T1 (ru)
AU (1) AU543215B2 (ru)
CA (1) CA1254567A (ru)
CS (1) CS249126B2 (ru)
DD (2) DD210270A5 (ru)
DE (1) DE3377280D1 (ru)
DK (1) DK85183A (ru)
ES (2) ES8503510A1 (ru)
FI (1) FI76334C (ru)
GR (1) GR77127B (ru)
HU (1) HU189906B (ru)
IE (1) IE54897B1 (ru)
IL (1) IL68131A (ru)
NO (1) NO162385B (ru)
NZ (1) NZ203577A (ru)
PH (1) PH19998A (ru)
PL (2) PL141640B1 (ru)
PT (1) PT76390B (ru)
RO (2) RO85382B (ru)
SU (1) SU1355130A3 (ru)
YU (2) YU44736B (ru)
ZA (1) ZA831781B (ru)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4576964A (en) * 1982-03-16 1986-03-18 Pfizer Inc. Substituted hexahydrobenzo[e]indene and octahydrophenanthrene CNS agents and pharmaceutical compositions thereof
US4670562A (en) * 1985-03-13 1987-06-02 Hoechst-Roussel Pharmaceuticals Inc. Dihydropyrrolo[1,2-b]isoquinolinedione oximes
US5629345A (en) * 1993-07-23 1997-05-13 Vide Pharmaceuticals Methods and compositions for ATP-sensitive K+ channel inhibition for lowering intraocular pressure
US5965620A (en) * 1993-07-23 1999-10-12 Vide Pharmaceuticals Methods and compositions for ATP-sensitive K+ channel inhibition for lowering intraocular pressure
CA2187257A1 (en) * 1995-10-12 1997-04-13 Enrique Luis Michelotti Aryl-substituted cycloalkanes and cycloalkenes and herbicidal use thereof
CN1075498C (zh) * 1997-05-08 2001-11-28 车庆明 一种查尔酮c甙和它的用途
US6316734B1 (en) 2000-03-07 2001-11-13 3M Innovative Properties Company Flexible circuits with static discharge protection and process for manufacture
ITGE20080051A1 (it) 2008-06-04 2009-12-05 Matteucci Francesco Metodo per la realizzazione di cavi diamantati rinforzati per il taglio di strutture e materiali in acciaio,calcestruzzo,acciaio e calcestruzzo,materiali litoidi o simili e cavo diamantato rinforzato ottenuto mediante tale metodo.
CN112778241A (zh) * 2021-03-09 2021-05-11 中国科学院兰州化学物理研究所 一种四氢呋喃乙酸及其酯类化合物的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3045020A (en) * 1962-07-17 x xcooa
FR1490023A (fr) * 1965-08-17 1967-07-28 Sandoz Sa Dérivés de l'isoquinoléine et leur préparation
US4260764A (en) * 1976-12-22 1981-04-07 Pfizer Inc. 9-Hydroxyoctahydrobenzo [C] quinolines and intermediates therefor
US4188495A (en) * 1977-11-14 1980-02-12 Pfizer Inc. 1,9-Dihydroxyoctahydrophenanthrenes and intermediates therefor

Also Published As

Publication number Publication date
PL141640B1 (en) 1987-08-31
PT76390A (en) 1983-04-01
DE3377280D1 (en) 1988-08-11
DD219765A5 (de) 1985-03-13
FI76334C (fi) 1988-10-10
KR880002412B1 (ko) 1988-11-08
PL240989A1 (en) 1984-06-18
KR880006969A (ko) 1988-07-25
DD210270A5 (de) 1984-06-06
IL68131A (en) 1986-07-31
KR840004111A (ko) 1984-10-06
HUT34146A (en) 1985-02-28
JPS63183542A (ja) 1988-07-28
NZ203577A (en) 1985-09-13
FI830857L (fi) 1983-09-17
GR77127B (ru) 1984-09-07
ES520630A0 (es) 1985-03-01
IE830559L (en) 1983-09-16
PL141501B1 (en) 1987-07-31
NO162385B (no) 1989-09-11
AR240936A2 (es) 1991-03-27
CS249126B2 (en) 1987-03-12
AU1244883A (en) 1983-09-22
SU1355130A3 (ru) 1987-11-23
JPS58170724A (ja) 1983-10-07
DK85183D0 (da) 1983-02-24
RO85382B (ro) 1984-11-30
US4476131A (en) 1984-10-09
PT76390B (en) 1986-02-03
YU60683A (en) 1986-04-30
ES527075A0 (es) 1985-04-16
RO88221B (ro) 1986-01-02
CA1254567A (en) 1989-05-23
ZA831781B (en) 1983-11-30
PL245846A1 (en) 1984-08-27
AR240936A1 (es) 1991-03-27
IL68131A0 (en) 1983-06-15
FI830857A0 (fi) 1983-03-15
HU189906B (en) 1986-08-28
IE54897B1 (en) 1990-03-14
EP0090516A1 (en) 1983-10-05
ES8503510A1 (es) 1985-03-01
DK85183A (da) 1983-09-17
NO830900L (no) 1983-09-19
KR870001126B1 (ko) 1987-06-09
RO88221A (ro) 1985-12-30
YU175785A (en) 1986-08-31
JPH0260653B2 (ru) 1990-12-17
EP0090516B1 (en) 1988-07-06
FI76334B (fi) 1988-06-30
RO85382A (ro) 1984-11-25
YU44736B (en) 1991-02-28
YU44899B (en) 1991-04-30
ATE35544T1 (de) 1988-07-15
AU543215B2 (en) 1985-04-04
ES8504097A1 (es) 1985-04-16

Similar Documents

Publication Publication Date Title
EP0184909A3 (en) Bioelectrochemical assay and apparatus
ZA846467B (en) Pyrimido(4,5-q)quinolines and intermediants
PH21385A (en) 7-substituted quinoline and naphthyridine antibacterial agents
PH14909A (en) Octahydro pyrazolo(3,4-g)quinolines
GB8427544D0 (en) Pin chuck
GB2232819B (en) Magnetic chuck
GB8410624D0 (en) Tricyclic amines
PH19998A (en) Hexahydropyrrolo 1,2-a quinoline,hexahydro-1h-pyrido 1,2-a quinoline,hexahydrobenzo e indene and octahydrophenanthrene cns agents
IL85267A (en) Welding masks
ZA829422B (en) Hyperuretic agents
GB8718360D0 (en) Service tee
GB8413685D0 (en) Quinolone inotropic agents
ZA857767B (en) Ultra violet agents
GB8321953D0 (en) Acetanilides processes
GB8301531D0 (en) Polypropylene-containing mixtures
GR860330B (en) Vehicle washing equipment
ZA86472B (en) Vehicle washing equipment
IE823091L (en) Imidazo quinolines
IE821423L (en) Azabicyclo £4,3,0| nonyl and azabicyclo £4,4,0| decyl¹derivatives
IE890074L (en) Antiarrythmic agents
IE841594L (en) PYRROLO (2,1-a) ISOQUINOLINES
IE871498L (en) PYRRIDAZINO (4,5:3,4) PYRROLO (2,1-a) ISOQUINOLINES
PHUM7017Z (en) Multi-purpose dangling caddy
IE891185L (en) Azabicyclic compounds
GB8520332D0 (en) Bioelectrochemical process